CAMPBELL, CA–(Marketwired – April 30, 2018) – VIVUS,Inc. (NASDAQ: VVUS) (the “Company”), a biopharmaceutical company, today announced the addition of three [...]

MADRID, SPAIN and CAMBRIDGE, MA–(Marketwired – April 27, 2018) – 13th Annual Neurotech Investing & Partnering Conference in Boston, USA BioEquity Europe 2018 in Ghent, [...]

HOUSTON, TX–(Marketwired – April 26, 2018) – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical [...]

CALGARY, AB and SAN DIEGO, CA–(Marketwired – April 26, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), currently developing REOLYSIN® (pelareorep), an [...]

NEW YORK, NY–(Marketwired – April 25, 2018) – ELUCIDA ONCOLOGY, INC®, a biotechnology company focused on developing and commercializing a first-in-class, ultra-small [...]

CAMPBELL, CA–(Marketwired – April 25, 2018) – VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results and provide a business update for the first [...]